1.84

2.13% -0.04

After Hours: 1.83 -0.01 -0.54%

Compass Therapeutics Inc (CMPX)

Overview News Price History Financials Discussions Forecast

Compass Therapeutics Inc stock is traded at $1.84, with a volume of 408.20K. It is down -2.13% in the last 24 hours and up +16.46% over the past month. Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.

Previous Close:

$1.88

Open:

$1.99

24h Volume:

408.20K

Relative Volume:

0.95

Market Cap:

$247.66M

Revenue:

Net Income/Loss:

$-45.44M

P/E Ratio:

-4.973

EPS:

-0.37

Net Cash Flow:

$-42.28M

1W Performance:

+15.72%

1M Performance:

+16.46%

6M Performance:

-7.07%

1Y Performance:

-6.60%

1-Day Range:

$1.72

$1.99

1-Week Range:

$1.58

$1.99

52-Week Range:

$0.765

$2.34

Compass Therapeutics Inc Stock (CMPX) Company Profile

Name

Compass Therapeutics Inc

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

617-500-8099

Address

80 GUEST STREET, BOSTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

CMPX's Discussions on Twitter

Compass Therapeutics Inc Stock (CMPX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-31-23	Initiated	Jefferies	Buy
Jan-27-23	Initiated	Stifel	Buy
May-23-22	Resumed	H.C. Wainwright	Buy
Mar-15-22	Initiated	Ladenburg Thalmann	Buy
Jan-19-22	Initiated	B. Riley Securities	Buy
Dec-22-21	Initiated	Raymond James	Outperform
Dec-20-21	Initiated	SVB Leerink	Outperform
Dec-15-21	Initiated	Wedbush	Outperform

View All

Compass Therapeutics Inc Stock (CMPX) Latest News

05:29 AM

Compass Therapeutics, Inc. (NASDAQ:CMPX) Short Interest Up 23.7% in September - MarketBeat

05:29 AM

03:30 AM

Rhumbline Advisers Takes Position in Perma-Fix Environmental Services, Inc. (NASDAQ:PESI) - Defense World

03:30 AM

Sep 29, 2024

Analyzing Neurocrine Biosciences (NASDAQ:NBIX) and Compass Therapeutics (NASDAQ:CMPX) - Defense World

Sep 29, 2024

Sep 26, 2024

PCM Fund Inc. (NYSE:PCM) Short Interest Down 36.3% in September - Defense World

Sep 26, 2024

Federated Hermes Inc. Has $51,000 Holdings in Deluxe Co. (NYSE:DLX) - Defense World

Sep 26, 2024

Sep 25, 2024

Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR

Sep 25, 2024

Was anything positive for Compass Therapeutics Inc (CMPX) stock last session? - US Post News

Sep 25, 2024

Compass Therapeutics Inc Inc. (CMPX) Price Performance: The Role of Supply and Demand - The InvestChronicle

Sep 25, 2024

TSX Communication Services Capped Index (TTTS) QuotePress Release - The Globe and Mail

Sep 25, 2024

Sep 23, 2024

Compass Diversified (NYSE:CODI) Insider Acquires $109,350.00 in Stock - Defense World

Sep 23, 2024

Balance Sheet Insights: Compass Therapeutics Inc (CMPX)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex

Sep 23, 2024

Oppenheimer Asset Management Inc. Invests $195,000 in Compass Minerals International, Inc. (NYSE:CMP) - Defense World

Sep 23, 2024

Sep 19, 2024

Compass, Inc. (NYSE:COMP) Short Interest Down 6.0% in August - Defense World

Sep 19, 2024

Excalibur (Cayman) Ltd Svf Sells 7,500,000 Shares of Compass, Inc. (NYSE:COMP) Stock - Defense World

Sep 19, 2024

Sep 18, 2024

A stock that deserves closer examination: Compass Therapeutics Inc (CMPX) - US Post News

Sep 18, 2024

Sep 17, 2024

Ladenburg Thalmann Upgrades Compass Therapeutics (CMPX) - MSN

Sep 17, 2024

Head-To-Head Analysis: Galera Therapeutics (NASDAQ:GRTX) & Galectin Therapeutics (NASDAQ:GALT) - Defense World

Sep 17, 2024

Sep 16, 2024

Ladenburg raises Compass Therapeutics shares to Buy rating with no target change - Investing.com Canada

Sep 16, 2024

Compass Therapeutics (NASDAQ:CMPX) Lifted to Buy at LADENBURG THALM/SH SH - MarketBeat

Sep 16, 2024

Sep 13, 2024

Executive team - Compass Pathways

Sep 13, 2024

Sep 08, 2024

National Bank of Canada FI Boosts Position in VICI Properties Inc. (NYSE:VICI) - Defense World

Sep 08, 2024

Sep 06, 2024

Upward Trajectory: Compass Therapeutics Inc (CMPX) Posts a Slidee, Closing at 1.49 - The Dwinnex

Sep 06, 2024

Sep 05, 2024

Enphase Energy, Inc. (NASDAQ:ENPH) Shares Sold by Panagora Asset Management Inc. - Defense World

Sep 05, 2024

Panagora Asset Management Inc. Invests $323,000 in Ring Energy, Inc. (NYSEAMERICAN:REI) - Defense World

Sep 05, 2024

Fox Co. (NASDAQ:FOXA) Shares Sold by Panagora Asset Management Inc. - Defense World

Sep 05, 2024

Genworth Financial, Inc. (NYSE:GNW) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - Defense World

Sep 05, 2024

Tobam Has $3.27 Million Position in Meta Platforms, Inc. (NASDAQ:META) - Defense World

Sep 05, 2024

Panagora Asset Management Inc. Lowers Stake in Quad/Graphics, Inc. (NYSE:QUAD) - Defense World

Sep 05, 2024

Bank of New York Mellon Corp Acquires 22,310 Shares of ICU Medical, Inc. (NASDAQ:ICUI) - Defense World

Sep 05, 2024

Panagora Asset Management Inc. Purchases New Stake in Wingstop Inc. (NASDAQ:WING) - Defense World

Sep 05, 2024

Panagora Asset Management Inc. Sells 2,087 Shares of MSA Safety Incorporated (NYSE:MSA) - Defense World

Sep 05, 2024

Sep 04, 2024